SEVERANCE AGREEMENT FOR DAVID M. FLOYDSeverance Agreement • March 23rd, 2005 • Pharmacopeia Drug Discovery Inc • Services-commercial physical & biological research • New Jersey
This SEVERANCE AGREEMENT (the “Agreement”) is made and entered into as of the 7th day of January, 2005, by and between PHARMACOPEIA DRUG DISCOVERY, INC., a Delaware corporation (hereinafter, the “Company”), and David M. Floyd an individual (hereinafter, “Employee”).
ContractConsulting Agreement • March 23rd, 2005 • Pharmacopeia Drug Discovery Inc • Services-commercial physical & biological research
February 25, 2004 Stephen A. Spearman, Ph.D., MBA Executive Vice President Chief Operating Officer, Pharmacopeia Drug Discovery, Inc.
SEVERANCE AGREEMENT FOR BRIAN M. POSNERSeverance Agreement • March 23rd, 2005 • Pharmacopeia Drug Discovery Inc • Services-commercial physical & biological research • New Jersey
This SEVERANCE AGREEMENT (the “Agreement”) is made and entered into as of the 8th day of February, 2005, by and between PHARMACOPEIA DRUG DISCOVERY, INC., a Delaware corporation (hereinafter, the “Company”), and Brian M. Posner, an individual (hereinafter, “Employee”).
